A cellular model of Alzheimer's disease therapeutic efficacy: PKC activation reverses Aβ-induced biomarker abnormality on cultured fibroblasts
PKC signaling is critical for the non-toxic degradation of amyloid precursor protein (APP) and inhibition of GSK3β, which controls phosphorylation of tau protein in Alzheimer's disease (AD). Thus the misregulation of PKC signaling could contribute to the origins of AD. Bryostatin, a potent PKC...
Main Authors: | Tapan K. Khan, Thomas J. Nelson, Vishal A. Verma, Paul A. Wender, Daniel L. Alkon |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2009-05-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996109000308 |
Similar Items
-
Evaluation of Toxic Amyloid β42 Oligomers in Rat Primary Cerebral Cortex Cells and Human iPS-derived Neurons Treated with 10-Me-Aplog-1, a New PKC Activator
by: Kazuma Murakami, et al.
Published: (2020-02-01) -
Programming of neurotoxic cofactor CXCL-10 in HIV-1-associated dementia: abrogation of CXCL-10-induced neuro-glial toxicity in vitro by PKC activator
by: Mehla Rajeev, et al.
Published: (2012-10-01) -
PKC-α Triggers EGFR Ubiquitination, Endocytosis and ERK Activation in Podocytes Stimulated with High Glucose
by: Chun-Tao Lei, et al.
Published: (2017-05-01) -
PKC activation during training restores mushroom spine synapses and memory in the aged rat
by: Jarin Hongpaisan, et al.
Published: (2013-07-01) -
PKCα is a Potentially Useful Marker for Planning Individualized Radiotherapy for Nasopharyngeal Carcinoma
by: Zhang J, et al.
Published: (2021-03-01)